Oppenheimer & CO Inc Zoetis Inc. Transaction History

Oppenheimer & CO Inc

$6.52 Billion
Q4 2024

A detailed history of Oppenheimer & CO Inc transactions in Zoetis Inc. stock. As of the latest transaction made, Oppenheimer & CO Inc holds 93,114 shares of ZTS stock, worth $16 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

93,114

Previous 54,000 72.43%

Holding current value

$16 Million

Previous $10.6 Million 43.8%

% of portfolio

0.23%

Previous 0.16%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 04, 2025	BUY	$162.24 - $194.42 $6.35 Million - $7.6 Million	39,114 Added 72.43%	93,114 $15.2 Million
Q3 2024 Nov 05, 2024	BUY	$172.58 - $196.48 $87,843 - $100,008	509 Added 0.95%	54,000 $10.6 Million
Q2 2024 Aug 07, 2024	SELL	$145.54 - $178.83 $141,028 - $173,286	-969 Reduced 1.78%	53,491 $9.27 Million
Q1 2024 May 06, 2024	SELL	$165.67 - $199.94 $36,613 - $44,186	-221 Reduced 0.4%	54,460 $9.22 Million
Q4 2023 Feb 13, 2024	SELL	$151.44 - $200.09 $160,526 - $212,095	-1,060 Reduced 1.9%	54,681 $10.8 Million
Q3 2023 Nov 07, 2023	SELL	$167.14 - $192.77 $964,397 - $1.11 Million	-5,770 Reduced 9.38%	55,741 $9.7 Million
Q2 2023 Aug 02, 2023	SELL	$160.94 - $186.23 $2,092 - $2,420	-13 Reduced 0.02%	61,511 $10.6 Million
Q1 2023 May 10, 2023	BUY	$145.48 - $175.02 $404,725 - $486,905	2,782 Added 4.74%	61,524 $10.2 Million
Q4 2022 Feb 07, 2023	SELL	$131.14 - $157.47 $264,640 - $317,774	-2,018 Reduced 3.32%	58,742 $8.61 Million
Q3 2022 Nov 14, 2022	SELL	$148.29 - $182.55 $336,766 - $414,571	-2,271 Reduced 3.6%	60,760 $9.01 Million
Q2 2022 Aug 08, 2022	SELL	$155.97 - $200.09 $302,113 - $387,574	-1,937 Reduced 2.98%	63,031 $10.8 Million
Q1 2022 May 12, 2022	SELL	$181.39 - $234.03 $1.39 Million - $1.79 Million	-7,645 Reduced 10.53%	64,968 $12.3 Million
Q4 2021 Feb 02, 2022	BUY	$193.69 - $247.03 $174,708 - $222,821	902 Added 1.26%	72,613 $17.7 Million
Q3 2021 Nov 12, 2021	SELL	$189.29 - $209.69 $3.43 Million - $3.8 Million	-18,143 Reduced 20.19%	71,711 $13.9 Million
Q2 2021 Aug 03, 2021	SELL	$155.9 - $187.99 $1.36 Million - $1.64 Million	-8,706 Reduced 8.83%	89,854 $16.7 Million
Q1 2021 May 10, 2021	SELL	$144.0 - $169.39 $4.89 Million - $5.75 Million	-33,928 Reduced 25.61%	98,560 $15.5 Million
Q4 2020 Feb 11, 2021	BUY	$157.07 - $174.35 $623,724 - $692,343	3,971 Added 3.09%	132,488 $21.9 Million
Q3 2020 Nov 13, 2020	BUY	$137.1 - $165.37 $4.62 Million - $5.58 Million	33,716 Added 35.57%	128,517 $21.3 Million
Q2 2020 Aug 11, 2020	SELL	$111.92 - $142.53 $1.88 Million - $2.4 Million	-16,821 Reduced 15.07%	94,801 $13 Million
Q1 2020 May 08, 2020	SELL	$92.66 - $144.94 $2.46 Million - $3.85 Million	-26,548 Reduced 19.21%	111,622 $13.1 Million
Q4 2019 Feb 07, 2020	BUY	$116.25 - $133.25 $728,771 - $835,344	6,269 Added 4.75%	138,170 $18.3 Million
Q3 2019 Oct 31, 2019	SELL	$112.57 - $128.43 $860,485 - $981,718	-7,644 Reduced 5.48%	131,901 $16.4 Million
Q2 2019 Aug 09, 2019	SELL	$97.98 - $114.28 $348,808 - $406,836	-3,560 Reduced 2.49%	139,545 $15.8 Million
Q1 2019 Apr 24, 2019	BUY	$81.56 - $100.67 $271,921 - $335,633	3,334 Added 2.39%	143,105 $14.4 Million
Q4 2018 Jan 29, 2019	BUY	$79.28 - $95.27 $526,022 - $632,116	6,635 Added 4.98%	139,771 $12 Million
Q3 2018 Oct 26, 2018	BUY	$83.5 - $93.23 $574,396 - $641,329	6,879 Added 5.45%	133,136 $12.2 Million
Q2 2018 Aug 10, 2018	SELL	$79.9 - $89.2 $261,512 - $291,951	-3,273 Reduced 2.53%	126,257 $10.8 Million
Q1 2018 May 01, 2018	BUY	$71.51 - $84.69 $1.82 Million - $2.16 Million	25,479 Added 24.49%	129,530 $10.8 Million
Q4 2017 Feb 07, 2018	SELL	$63.24 - $72.8 $189,150 - $217,744	-2,991 Reduced 2.79%	104,051 $7.5 Million
Q3 2017 Nov 09, 2017	BUY	$59.73 - $65.4 $6.39 Million - $7 Million	107,042	107,042 $6.83 Million

Others Institutions Holding ZTS

# of Institutions

1,961

Shares Held

411M

Call Options Held

1.01M

Put Options Held

1.08M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $80.6B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer & CO Inc with notifications on news.

Account

Oppenheimer & CO Inc Zoetis Inc. Transaction History